ghk cu.peptide GHK-Cu 100mg | Copper Peptide for Research GHK Copper Peptide | GHK-Cu
Description
Quality assurance supports consistent results
When examining the effects of BPC 157 on tail spasticity the results reported that development of spasticity began earlier in the test subjects treated with the peptide in comparison to the corresponding controls
Boachie J, Adaikalakoteswari A, Samavat J, Saravanan P
at the 20 mg/kg mouse dose, the human-equivalent dose would be approximately 1.6 mg/kg
